Abstract:As a kind of proteolytic enzyme extracted from earthworms, lumbrokinase has been used as an antithrombotic drug clinically. Nevertheless, its potential in anti-cancer, especially in anti-non-small cell lung cancer (NSCLC), as a single form of treatment or in combination with other therapies, is still poorly understood. In this study, we explored the anti-tumor role and the responsive molecular mechanisms of lumbrokinase in suppressing tumor angiogenesis and chemoresistance development in NSCLC and its clinical potential in combination with bevacizumab and chemotherapeutics. Lumbrokinase was found to inhibit cell proliferation in a concentration-dependent manner and caused metastasis suppression and apoptosis induction to varying degrees in NSCLC cells. Lumbrokinase enhanced the anti-angiogenesis efficiency of bevacizumab by down-regulating BPTF expression, decreasing its anchoring at the VEGF promoter region and subsequent VEGF expression and secretion. Furthermore, lumbrokinase treatment reduced IC50 values of chemotherapeutics and improved their cytotoxicity in parental and chemo-resistant NSCLC cells via inactivating the NF-κB pathway, inhibiting the expression of COX-2 and subsequent secretion of PGE2. LPS-induced NF-κB activation reversed its inhibition on NSCLC cell proliferation and its synergy with chemotherapeutic cytotoxicity, while COX-2 inhibitor celecoxib treatment boosted such effects. Lumbrokinase combined with bevacizumab, paclitaxel, or vincristine inhibited the xenograft growth of NSCLC cells in mice more significantly than a single treatment. In conclusion, lumbrokinase inhibited NSCLC survival and sensitized NSCLC cells to bevacizumab or chemotherapeutics treatment by targeted down-regulation of BPTF/VEGF signaling and inactivation of NF-κB/COX-2 signaling, respectively. The combinational applications of lumbrokinase with bevacizumab or chemotherapeutics are expected to be developed as promising candidate therapeutic strategies to improve the efficacy of the original monotherapy in anti-NSCLC.

Expression of biologically active anti-thrombosis protein lumbrokinase in edible sunflower seed kernel

Expression, purification, and characterization of recombinant lumbrokinase PI239 in Escherichia coli.

Cloning and Expression of One Fibrinolytic Enzyme from Bacillus Sp. Zlw-2

Efficient expression of nattokinase in Bacillus licheniformis: host strain construction and signal peptide optimization

Functional expression and purification of bovine enterokinase light chain in recombinant Escherichia coli.

亲和超滤结合Uplc‐Q‐Tof‐Ms快速筛选桃仁中凝血酶抑制活性成分

Lumbrokinase Extracted from Earthworms Synergizes with Bevacizumab and Chemotherapeutics in Treating Non-Small Cell Lung Cancer by Targeted Inactivation of BPTF/VEGF and NF-κB/COX-2 Signaling

A Novel Fibrinolytic Protein From Pheretima vulgaris: Purification, Identification, Antithrombotic Evaluation, and Mechanisms Investigation

Overexpression of the Bioactive Lunasin Peptide in Soybean and Evaluation of Its Anti-Inflammatory and Anti-Cancer Activities in Vitro.

Anticoagulant mechanism, pharmacological activity, and assessment of preclinical safety of a novel fibrin(ogen)olytic serine protease from leaves of Leucas indica

Establishment of detection method for the biological activity of Lumbrokinase

High level expression of kringle 5 fragment of plasminogen in Pichia pastoris

Stepwise modifications of genetic parts reinforce the secretory production of nattokinase in Bacillus subtilis

Expression Of Biologically Active Kringle 5 Domain Of Human Plasminogen In Escherichia Coli

[Cloning and Expression of Luffin-a Gene from the Seeds of Luffa Cylindrical].

An effective combination of codon optimization, gene dosage, and process optimization for high-level production of fibrinolytic enzyme in Komagataella phaffii (Pichia pastoris)

Heterologous expression of nattokinase from B. subtilis natto using Pichia pastoris GS115 and assessment of its thrombolytic activity

[Molecular Cloning and Expression of the Cdna Encoding Angiogenesis Inhibitor K4K5 with Pichia Pastoris].

Recombinant Plasminogen Activator of the Sandworm (Perinereis aibuhitensis) Expression in Escherichia coli

High and Economical Nattokinase Production with Acetoin as a Useful Byproduct from Soybean Milk and Glucose

Strain Screening, Fermentation, Separation, and Encapsulation for Production of Nattokinase Functional Food